Walgreens Boots Alliance to Participate in TD Cowen's 8th Annual FutureHealth Conference
Get Alerts WBA Hot Sheet
Overall Analyst Rating:
NEUTRAL (

Dividend Yield: 9.5%
EPS Growth %: -45.7%
Join SI Premium – FREE
DEERFIELD, Ill.--(BUSINESS WIRE)-- Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that Executive Vice President and President, U.S. Healthcare, John Driscoll, will present at TD Cowen's 8th Annual FutureHealth Conference on Thursday, Sept. 21 at 3:00 p.m. ET. Driscoll will discuss the Company’s healthcare strategy and ongoing transformation of WBA’s U.S. Healthcare segment into a value-based care delivery model.
The appearance will be webcast live and can be accessed through the Walgreens Boots Alliance investor relations website at https://investor.walgreensbootsalliance.com/news-and-events/default.aspx#event.
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities.
A trusted, global innovator in retail pharmacy with approximately 13,000 locations across the U.S., Europe and Latin America, WBA plays a critical role in the healthcare ecosystem. The Company is reimagining local healthcare and well-being for all as part of its purpose – to create more joyful lives through better health. Through dispensing medicines, improving access to a wide range of health services, providing high quality health and beauty products and offering anytime, anywhere convenience across its digital platforms, WBA is shaping the future of healthcare.
WBA employs more than 325,000 people and has a presence in nine countries through its portfolio of consumer brands: Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Additionally, WBA has a portfolio of healthcare-focused investments located in several countries, including China and the U.S.
The Company is proud of its contributions to healthy communities, a healthy planet, an inclusive workplace and a sustainable marketplace. WBA has been recognized for its commitment to operating sustainably: the Company is an index component of the Dow Jones Sustainability Indices (DJSI) and was named to the 100 Best Corporate Citizens 2022.
More Company information is available at www.walgreensbootsalliance.com.
(WBA-GEN)
Cautionary Note Regarding Forward-Looking Statements: All statements in this release and related conference and webcast that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including those described in Item 1A (Risk Factors) of our Form 10-K for the fiscal year ended August 31, 2022 and in other documents that we file or furnish with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially. These forward-looking statements speak only as of the date they are made. We do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230913793604/en/
WBA Media Relations
USA / Jim Cohn +1 224 813 9057
International +44 (0)20 7980 8585
WBA Investor Relations
Tiffany Kanaga +1 847 315 2922
Source: Walgreens Boots Alliance
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Texas Couple Recognized with St. Jude Hero Among Us Award
- IDC Forecasts Revenue for Artificial Intelligence Software Will Reach $307 Billion Worldwide in 2027
- Core One Labs’ Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer’s and Parkinson’s, Showing Potential to Outperform Current Treatment Methods
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!